
Harsh Gajjar Deepak
About Harsh Gajjar Deepak
Data last updated:
Harsh Gajjar Deepak is a Director at Patco Pharmaceuticals Private Limited (since 2019), Director at Patco Exports Pvt Ltd (since 2011) and Designated Partner at Elicura Healthcare Llp (since 2023). The companies operate in E-Commerce, Machinery and Equipment and Business Services. The 2 current companies with reported revenue have a combined latest revenue of ₹9.61 Cr; the largest is Patco Pharmaceuticals Private Limited at ₹4.92 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 01 Mar 2019 | 2019 | ₹4.92 Cr (FY 2024) | Active | |
| Director | 05 Oct 2011 | 1992 | ₹4.69 Cr (FY 2025) | Active | |
| Designated Partner | 02 Nov 2023 | 2023 | Active |
Board colleagues of Harsh Gajjar Deepak
| Name | DIN | Company | Designation |
|---|---|---|---|
| Deepak Natwarlal Gajjar | 01022491 | Patco Pharmaceuticals Private Limited , Patco Exports Pvt Ltd and 1 more | Director |
| Jyoti Deepak Gajjar | 01875708 | Patco Pharmaceuticals Private Limited , Patco Exports Pvt Ltd | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Harsh Gajjar Deepak
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Harsh Gajjar Deepak
Harsh Gajjar Deepak currently holds 3 directorships: Patco Pharmaceuticals Private Limited (Director, since 01 Mar 2019, revenue ₹4.92 Cr (FY 2024)); Patco Exports Pvt Ltd (Director, since 05 Oct 2011, revenue ₹4.69 Cr (FY 2025)); Elicura Healthcare Llp (Designated Partner, since 02 Nov 2023).
Harsh Gajjar Deepak was first appointed on 05 Oct 2011 as Director at Patco Exports Pvt Ltd. The most recent appointment on record is 02 Nov 2023 at Elicura Healthcare Llp.
The 2 current companies of Harsh Gajjar Deepak that report revenue have a combined latest revenue of ₹9.61 Cr: Patco Pharmaceuticals Private Limited ₹4.92 Cr (FY 2024); Patco Exports Pvt Ltd ₹4.69 Cr (FY 2025).
The current boards of Harsh Gajjar Deepak's companies include Deepak Natwarlal Gajjar (Patco Pharmaceuticals Private Limited), Jyoti Deepak Gajjar (Patco Pharmaceuticals Private Limited).